[
    {
        "text": "So, I have to say first, thanks to ACS",
        "start": 0.5,
        "duration": 3.92
    },
    {
        "text": "and to C&EN and to the community",
        "start": 4.42,
        "duration": 1.64
    },
    {
        "text": "for selecting me for this recognition,",
        "start": 6.06,
        "duration": 2.92
    },
    {
        "text": "and I'm very fortunate of being here",
        "start": 8.98,
        "duration": 2.61
    },
    {
        "text": "and being part of this group.",
        "start": 11.59,
        "duration": 2.24
    },
    {
        "text": "So the title of my talk is",
        "start": 13.83,
        "duration": 1.84
    },
    {
        "text": "\"Chemistry to enable drug discovery",
        "start": 15.67,
        "duration": 1.97
    },
    {
        "text": "in neuroscience and also rare diseases.\"",
        "start": 17.64,
        "duration": 2.97
    },
    {
        "text": "But before I show you a\nlittle bit about my research",
        "start": 20.61,
        "duration": 2.44
    },
    {
        "text": "I want to introduce\nyou with my background.",
        "start": 23.05,
        "duration": 3.063
    },
    {
        "text": "So, as many of the good things in my life,",
        "start": 27.606,
        "duration": 3.694
    },
    {
        "text": "science to me came as a game",
        "start": 31.3,
        "duration": 1.76
    },
    {
        "text": "so, when I was very\nlittle, I was playing with",
        "start": 33.06,
        "duration": 2.86
    },
    {
        "text": "LEGO sets, also with getting my hands",
        "start": 37.0,
        "duration": 2.31
    },
    {
        "text": "on chemistry sets, and\nI was also designing",
        "start": 39.31,
        "duration": 2.19
    },
    {
        "text": "my first experiments in the backyard,",
        "start": 41.5,
        "duration": 2.65
    },
    {
        "text": "building like trebuchets and catapults",
        "start": 44.15,
        "duration": 2.1
    },
    {
        "text": "that my father allowed me to,",
        "start": 46.25,
        "duration": 1.9
    },
    {
        "text": "that my parents allowed me to do,",
        "start": 48.15,
        "duration": 1.86
    },
    {
        "text": "and it was all of this experiences",
        "start": 50.01,
        "duration": 2.09
    },
    {
        "text": "at the very start of my career",
        "start": 53.209,
        "duration": 3.751
    },
    {
        "text": "that allowed me to get a sense of",
        "start": 56.96,
        "duration": 2.04
    },
    {
        "text": "what the scientific method was.",
        "start": 59.0,
        "duration": 1.833
    },
    {
        "text": "How do you design hypothesis,",
        "start": 62.606,
        "duration": 1.954
    },
    {
        "text": "how you design experiments\nand then corroborate",
        "start": 64.56,
        "duration": 3.361
    },
    {
        "text": "this hypothesis, and also\nsometimes when things",
        "start": 67.921,
        "duration": 2.539
    },
    {
        "text": "don't work, you go and try\nto tweak your hypothesis,",
        "start": 70.46,
        "duration": 3.19
    },
    {
        "text": "and see, and try to learn new things.",
        "start": 73.65,
        "duration": 3.03
    },
    {
        "text": "And it was a thrill to discover",
        "start": 76.68,
        "duration": 1.72
    },
    {
        "text": "and learn new things which inspired me to",
        "start": 78.4,
        "duration": 2.32
    },
    {
        "text": "follow science and that instinct\nstarted growing and growing",
        "start": 80.72,
        "duration": 4.36
    },
    {
        "text": "until eventually I\ndecided to start a career",
        "start": 85.08,
        "duration": 4.26
    },
    {
        "text": "pursuing something that",
        "start": 90.21,
        "duration": 1.98
    },
    {
        "text": "allowed me to use chemistry\nto improve human health.",
        "start": 92.19,
        "duration": 2.72
    },
    {
        "text": "And that's why, back in Costa Rica,",
        "start": 94.91,
        "duration": 2.56
    },
    {
        "text": "I started my Pharm.D, and\nwith my pharmacy school",
        "start": 97.47,
        "duration": 2.86
    },
    {
        "text": "I was able to perform research",
        "start": 100.33,
        "duration": 3.82
    },
    {
        "text": "in natural products, I was\nisolating new natural products,",
        "start": 104.15,
        "duration": 4.67
    },
    {
        "text": "and I also characterizing\ntheir biological activity.",
        "start": 108.82,
        "duration": 3.31
    },
    {
        "text": "And once I'd finished my Pharm.D,",
        "start": 112.13,
        "duration": 2.16
    },
    {
        "text": "I knew that I wanted a\nmore hands-on training",
        "start": 114.29,
        "duration": 2.75
    },
    {
        "text": "in organic chemistry.",
        "start": 117.04,
        "duration": 1.93
    },
    {
        "text": "and that's why went for my master's",
        "start": 118.97,
        "duration": 1.98
    },
    {
        "text": "and here I was working with Dr. PÃ©rez",
        "start": 120.95,
        "duration": 2.7
    },
    {
        "text": "and Dr. Lamoureux",
        "start": 123.65,
        "duration": 2.0
    },
    {
        "text": "in doing the synthesis",
        "start": 126.77,
        "duration": 1.24
    },
    {
        "text": "of this funny looking molecules that you",
        "start": 128.01,
        "duration": 1.87
    },
    {
        "text": "see here that are called\nFerrocene-naphthoquinones,",
        "start": 129.88,
        "duration": 4.05
    },
    {
        "text": "and there I was interested in\ntheir anti-malarial activity,",
        "start": 133.93,
        "duration": 2.95
    },
    {
        "text": "and also their\nelectrochemical properties.",
        "start": 136.88,
        "duration": 2.66
    },
    {
        "text": "And it was during these years that",
        "start": 139.54,
        "duration": 2.49
    },
    {
        "text": "I learned, and I get an acquaintance of the",
        "start": 142.03,
        "duration": 4.34
    },
    {
        "text": "field of medicinal chemistry.",
        "start": 146.37,
        "duration": 2.007
    },
    {
        "text": "And I was very interested\nin learning",
        "start": 148.377,
        "duration": 3.453
    },
    {
        "text": "more about that and getting\ntrained in this area,",
        "start": 151.83,
        "duration": 2.78
    },
    {
        "text": "and that is why I went\nto Vanderbilt University.",
        "start": 154.61,
        "duration": 2.78
    },
    {
        "text": "I flew to Nashville and I did\nmy PhD in chemical biology,",
        "start": 157.39,
        "duration": 3.98
    },
    {
        "text": "and then to expand my chemistry skillset",
        "start": 161.37,
        "duration": 3.54
    },
    {
        "text": "I went to MIT for a postdoctoral position.",
        "start": 164.91,
        "duration": 3.253
    },
    {
        "text": "While at Vanderbilt I was working with",
        "start": 169.39,
        "duration": 2.08
    },
    {
        "text": "Dr. Craig Lindsley,",
        "start": 171.47,
        "duration": 1.83
    },
    {
        "text": "and I was lucky enough that in his lab",
        "start": 173.3,
        "duration": 4.33
    },
    {
        "text": "we are able to work in\ndifferent sub-fields",
        "start": 177.63,
        "duration": 2.59
    },
    {
        "text": "of organic synthesis, so I was working in",
        "start": 180.22,
        "duration": 1.69
    },
    {
        "text": "total synthesis, in medicinal chemistry,",
        "start": 181.91,
        "duration": 2.619
    },
    {
        "text": "and in the development of new methods.",
        "start": 184.529,
        "duration": 3.211
    },
    {
        "text": "But I was particularly interested\nin medicinal chemistry,",
        "start": 187.74,
        "duration": 2.4
    },
    {
        "text": "and here I was able to\nwork in different projects,",
        "start": 190.14,
        "duration": 2.62
    },
    {
        "text": "and get my hands on, and\nget a very good training.",
        "start": 192.76,
        "duration": 2.983
    },
    {
        "text": "For my post doc, I came to Boston,",
        "start": 196.69,
        "duration": 2.57
    },
    {
        "text": "I was working with Dr. Timothy Jamison,",
        "start": 199.26,
        "duration": 3.58
    },
    {
        "text": "and he, what he wanted to do,",
        "start": 202.84,
        "duration": 1.23
    },
    {
        "text": "was something that was very, very different",
        "start": 204.07,
        "duration": 2.25
    },
    {
        "text": "to what I did in my grad school.",
        "start": 206.32,
        "duration": 1.8
    },
    {
        "text": "So I was exposed to synthetic methods",
        "start": 208.12,
        "duration": 4.11
    },
    {
        "text": "that were something that I",
        "start": 213.08,
        "duration": 0.87
    },
    {
        "text": "have never tried before,\nlike photoredox chemistry",
        "start": 213.95,
        "duration": 2.53
    },
    {
        "text": "and also flow chemistry.",
        "start": 216.48,
        "duration": 1.47
    },
    {
        "text": "Flow chemistry is particularly challenging",
        "start": 217.95,
        "duration": 2.37
    },
    {
        "text": "coming from a total synthesis\nbackground and med-chem,",
        "start": 220.32,
        "duration": 2.37
    },
    {
        "text": "because in this one",
        "start": 222.69,
        "duration": 1.45
    },
    {
        "text": "you need to switch your\nbrain a little bit,",
        "start": 225.16,
        "duration": 4.36
    },
    {
        "text": "because what works in batch might",
        "start": 229.52,
        "duration": 2.32
    },
    {
        "text": "not work in flow, and vice versa.",
        "start": 231.84,
        "duration": 2.41
    },
    {
        "text": "So this was a great experience to",
        "start": 234.25,
        "duration": 3.23
    },
    {
        "text": "expand my chemistry horizons.",
        "start": 237.48,
        "duration": 4.89
    },
    {
        "text": "But, as I give you a hint before,",
        "start": 242.37,
        "duration": 3.31
    },
    {
        "text": "my passion lies at\nworking at the interface",
        "start": 245.68,
        "duration": 3.07
    },
    {
        "text": "of chemistry and biology,",
        "start": 248.75,
        "duration": 2.13
    },
    {
        "text": "and here I'm very keen\nto two specific fields,",
        "start": 250.88,
        "duration": 2.91
    },
    {
        "text": "which are chemical biology\nand medicinal chemistry.",
        "start": 253.79,
        "duration": 3.04
    },
    {
        "text": "In both of them, they\nare similar in the way",
        "start": 256.83,
        "duration": 2.38
    },
    {
        "text": "that they approach\nchemistry, in the terms that",
        "start": 259.21,
        "duration": 3.16
    },
    {
        "text": "you use your chemistry expertise to",
        "start": 262.37,
        "duration": 1.6
    },
    {
        "text": "manipulate biological systems.",
        "start": 263.97,
        "duration": 2.093
    },
    {
        "text": "Specifically I was interested more in",
        "start": 267.291,
        "duration": 3.141
    },
    {
        "text": "medicinal chemistry because you manipulate",
        "start": 270.432,
        "duration": 1.658
    },
    {
        "text": "the systems to develop\nnew therapeutic agents",
        "start": 272.09,
        "duration": 5.0
    },
    {
        "text": "and that's in line with\nwhat I wanted to do in life,",
        "start": 277.28,
        "duration": 2.96
    },
    {
        "text": "to create new medicines and help people.",
        "start": 280.24,
        "duration": 3.273
    },
    {
        "text": "So, when I started at Vanderbilt,",
        "start": 284.55,
        "duration": 3.4
    },
    {
        "text": "I started to work in\nschizophrenia research,",
        "start": 287.95,
        "duration": 3.57
    },
    {
        "text": "and schizophrenia is a very important",
        "start": 291.52,
        "duration": 2.33
    },
    {
        "text": "public health issue,\nespecially for mental health,",
        "start": 293.85,
        "duration": 2.72
    },
    {
        "text": "and although there's several reasons",
        "start": 296.57,
        "duration": 2.15
    },
    {
        "text": "the most important for me is that around",
        "start": 298.72,
        "duration": 1.6
    },
    {
        "text": "50% of the patients, they don't receive",
        "start": 300.32,
        "duration": 2.13
    },
    {
        "text": "the appropriate treatment.",
        "start": 302.45,
        "duration": 1.29
    },
    {
        "text": "And most of the time",
        "start": 303.74,
        "duration": 0.833
    },
    {
        "text": "it is because this treatment\ndoesn't exist for them.",
        "start": 304.573,
        "duration": 2.71
    },
    {
        "text": "That is why at Vanderbilt Center for",
        "start": 308.19,
        "duration": 2.62
    },
    {
        "text": "Neuroscience Drug Discovery we were",
        "start": 310.81,
        "duration": 1.93
    },
    {
        "text": "working on different strategies to",
        "start": 313.58,
        "duration": 3.57
    },
    {
        "text": "tackle the schizophrenia\nfrom a different angle,",
        "start": 317.15,
        "duration": 2.68
    },
    {
        "text": "and one of that different\nstrategies is the mGlu1 receptor.",
        "start": 319.83,
        "duration": 4.423
    },
    {
        "text": "MGlu1 stands for Metabotropic\nglutamate receptor subtype 1.",
        "start": 324.253,
        "duration": 4.297
    },
    {
        "text": "It's involved in many\nfunctions with the brain,",
        "start": 328.55,
        "duration": 3.43
    },
    {
        "text": "but we were particularly\ninterested in this target,",
        "start": 331.98,
        "duration": 2.39
    },
    {
        "text": "because in the literature, we found",
        "start": 334.37,
        "duration": 2.5
    },
    {
        "text": "that once you knock out the mGlu1",
        "start": 336.87,
        "duration": 4.2
    },
    {
        "text": "or the gene that encodes\nfor mGlu1 in mice,",
        "start": 341.07,
        "duration": 3.84
    },
    {
        "text": "they start suffering from a disruption",
        "start": 344.91,
        "duration": 2.41
    },
    {
        "text": "in prepulse inhibition,",
        "start": 347.32,
        "duration": 1.46
    },
    {
        "text": "and this is a feature\nthat is characteristic",
        "start": 348.78,
        "duration": 1.91
    },
    {
        "text": "in a subset of schizophrenic patients",
        "start": 350.69,
        "duration": 2.11
    },
    {
        "text": "and also bi-polar patients.",
        "start": 352.8,
        "duration": 1.563
    },
    {
        "text": "Another piece of data that\nwas really interesting",
        "start": 355.59,
        "duration": 2.26
    },
    {
        "text": "in the literature was that this gene",
        "start": 357.85,
        "duration": 4.32
    },
    {
        "text": "has a significant amount of SNPs,",
        "start": 362.17,
        "duration": 3.54
    },
    {
        "text": "and these SNPs are enriched in",
        "start": 365.71,
        "duration": 1.86
    },
    {
        "text": "schizophrenic and bipolar patients.",
        "start": 367.57,
        "duration": 1.75
    },
    {
        "text": "And then in our labs we established",
        "start": 370.33,
        "duration": 3.34
    },
    {
        "text": "that these SNPs, what they\ncause for the receptor",
        "start": 373.67,
        "duration": 3.1
    },
    {
        "text": "is that they decrease its functionality.",
        "start": 376.77,
        "duration": 4.49
    },
    {
        "text": "So now that we knew that,",
        "start": 381.26,
        "duration": 2.649
    },
    {
        "text": "we hypothesized that maybe if we",
        "start": 383.909,
        "duration": 2.901
    },
    {
        "text": "create a therapy that\ntargets the receptor's",
        "start": 386.81,
        "duration": 2.02
    },
    {
        "text": "function recovery, this\nwill be therapeutically",
        "start": 388.83,
        "duration": 2.93
    },
    {
        "text": "beneficial for this subset of patients.",
        "start": 391.76,
        "duration": 2.87
    },
    {
        "text": "But, at that time we didn't have the",
        "start": 394.63,
        "duration": 1.99
    },
    {
        "text": "chemical tools that allow\nus to activate the receptor",
        "start": 396.62,
        "duration": 2.98
    },
    {
        "text": "and answer this question properly.",
        "start": 399.6,
        "duration": 2.91
    },
    {
        "text": "And that is why I started a\nmedicinal chemistry campaign,",
        "start": 402.51,
        "duration": 3.85
    },
    {
        "text": "and starting with this heat\nand after numerous cycles",
        "start": 406.36,
        "duration": 5.0
    },
    {
        "text": "of design, synthesis, screening,",
        "start": 411.56,
        "duration": 2.34
    },
    {
        "text": "and pharmacokinetic\nproperties characterization,",
        "start": 413.9,
        "duration": 3.2
    },
    {
        "text": "we developed optimized mGlu1 PAMs,",
        "start": 417.1,
        "duration": 2.37
    },
    {
        "text": "and as during my\nintroduction, we will say it,",
        "start": 419.47,
        "duration": 3.17
    },
    {
        "text": "so PAMs are, stand for\nPositive Allosteric Modulators,",
        "start": 422.64,
        "duration": 4.25
    },
    {
        "text": "and these ones are the\nactivators that we needed",
        "start": 426.89,
        "duration": 2.13
    },
    {
        "text": "to do the target modulation studies.",
        "start": 429.02,
        "duration": 2.173
    },
    {
        "text": "This is just a taste of\nthe molecules so far,",
        "start": 432.19,
        "duration": 3.18
    },
    {
        "text": "first generation of mGlu1 PAMs.",
        "start": 435.37,
        "duration": 2.24
    },
    {
        "text": "This compound 605, the\ncompound is [inaudible] enough",
        "start": 437.61,
        "duration": 4.318
    },
    {
        "text": "for in vitro studies, and\nalso it's quite selective,",
        "start": 441.928,
        "duration": 4.592
    },
    {
        "text": "it's quite functionally selective.",
        "start": 446.52,
        "duration": 3.64
    },
    {
        "text": "And then when we test this compound",
        "start": 450.16,
        "duration": 3.02
    },
    {
        "text": "in a series of different mutants,",
        "start": 453.18,
        "duration": 2.3
    },
    {
        "text": "we found out that this kind of compounds",
        "start": 455.48,
        "duration": 2.15
    },
    {
        "text": "can activate this mutant,",
        "start": 457.63,
        "duration": 1.42
    },
    {
        "text": "so that's what we were looking in vitro,",
        "start": 459.05,
        "duration": 2.57
    },
    {
        "text": "but we needed to establish\nif this effect in vitro",
        "start": 461.62,
        "duration": 3.26
    },
    {
        "text": "translates to something\nthat is significant in vivo.",
        "start": 464.88,
        "duration": 3.74
    },
    {
        "text": "But when we tried to apply\nthis probe in in vivo studies",
        "start": 468.62,
        "duration": 4.05
    },
    {
        "text": "we find out it's\npharmacokinetic properties",
        "start": 472.67,
        "duration": 2.99
    },
    {
        "text": "were not optimal because the compounds",
        "start": 475.66,
        "duration": 1.95
    },
    {
        "text": "were unstable in plasma.",
        "start": 477.61,
        "duration": 2.86
    },
    {
        "text": "And then I proceed to\ncreate a second generation",
        "start": 480.47,
        "duration": 3.87
    },
    {
        "text": "of mGlu1 PAMs and you can see here",
        "start": 484.34,
        "duration": 2.24
    },
    {
        "text": "going from, these are just some examples,",
        "start": 486.58,
        "duration": 2.16
    },
    {
        "text": "going from green is good, yellow is bad,",
        "start": 488.74,
        "duration": 3.6
    },
    {
        "text": "we get the compound 4909,\nthat is a compound that",
        "start": 492.34,
        "duration": 3.71
    },
    {
        "text": "is optimized in most of it's properties,",
        "start": 496.05,
        "duration": 2.85
    },
    {
        "text": "it has a good potency and it has a good",
        "start": 498.9,
        "duration": 3.9
    },
    {
        "text": "physicochemical properties,\nand also, very important for us,",
        "start": 502.8,
        "duration": 4.58
    },
    {
        "text": "it has a much better in\nvivo pharmacokinetic profile;",
        "start": 507.38,
        "duration": 3.82
    },
    {
        "text": "now the compound is brain penetrant,",
        "start": 511.2,
        "duration": 1.94
    },
    {
        "text": "and it also has a half-life in rodents",
        "start": 513.14,
        "duration": 2.21
    },
    {
        "text": "of around five hours.",
        "start": 515.35,
        "duration": 2.033
    },
    {
        "text": "And with this probe, now\nwe started to explore",
        "start": 518.27,
        "duration": 3.9
    },
    {
        "text": "the biology of mGlu1",
        "start": 522.17,
        "duration": 2.81
    },
    {
        "text": "and its role in the brain\nand also in schizophrenia.",
        "start": 526.893,
        "duration": 2.937
    },
    {
        "text": "We can say that mGlu1\nactivation decreases the",
        "start": 529.83,
        "duration": 2.79
    },
    {
        "text": "dopamine striatal release,\nand that's a feature for",
        "start": 532.62,
        "duration": 3.54
    },
    {
        "text": "anti-psychotic activity.\nAlso in in vivo studies",
        "start": 536.16,
        "duration": 3.03
    },
    {
        "text": "now we have demonstrated\nthat mGlu1 activation",
        "start": 539.19,
        "duration": 2.84
    },
    {
        "text": "attenuates amphetamine disruptions\nin prepulse inhibition,",
        "start": 542.03,
        "duration": 5.0
    },
    {
        "text": "and this counts without\naffecting locomotor activity.",
        "start": 547.91,
        "duration": 3.14
    },
    {
        "text": "So essentially what we're seeing is an",
        "start": 551.05,
        "duration": 1.91
    },
    {
        "text": "anti-psychotic-like\neffect without sedation.",
        "start": 552.96,
        "duration": 3.45
    },
    {
        "text": "And that's something that\nyou will like in a treatment",
        "start": 556.41,
        "duration": 2.6
    },
    {
        "text": "for schizophrenics.",
        "start": 559.01,
        "duration": 3.54
    },
    {
        "text": "And this project, I'm very happy to say,",
        "start": 562.55,
        "duration": 1.91
    },
    {
        "text": "that it's moving forward at Vanderbilt,",
        "start": 564.46,
        "duration": 2.28
    },
    {
        "text": "and that I learn a good\ndeal of medicinal chemistry",
        "start": 566.74,
        "duration": 3.53
    },
    {
        "text": "during these years.",
        "start": 570.27,
        "duration": 1.473
    },
    {
        "text": "And also that treating schizophrenia",
        "start": 573.057,
        "duration": 3.873
    },
    {
        "text": "as a genetic disease provide me a",
        "start": 576.93,
        "duration": 2.61
    },
    {
        "text": "very good background for my current role",
        "start": 579.54,
        "duration": 3.218
    },
    {
        "text": "at Vertex Pharmaceuticals.",
        "start": 582.758,
        "duration": 2.702
    },
    {
        "text": "Here I'm dealing with rare diseases.",
        "start": 585.46,
        "duration": 3.12
    },
    {
        "text": "So a rare disease is a condition that",
        "start": 588.58,
        "duration": 1.54
    },
    {
        "text": "affects a small subset of patients,",
        "start": 590.12,
        "duration": 1.89
    },
    {
        "text": "but once you combine\nthem all it accounts for",
        "start": 592.01,
        "duration": 2.29
    },
    {
        "text": "almost 10% of the population of the US,",
        "start": 594.3,
        "duration": 2.64
    },
    {
        "text": "and half of them are kids.",
        "start": 596.94,
        "duration": 1.81
    },
    {
        "text": "And that's really worrisome.",
        "start": 598.75,
        "duration": 2.1
    },
    {
        "text": "There's thousands of rare diseases,",
        "start": 600.85,
        "duration": 2.53
    },
    {
        "text": "most of them have a genetic origin,",
        "start": 603.38,
        "duration": 5.0
    },
    {
        "text": "they are hard to diagnose\nand there are few",
        "start": 609.51,
        "duration": 1.96
    },
    {
        "text": "treatments approved for these diseases.",
        "start": 611.47,
        "duration": 2.34
    },
    {
        "text": "And that's why at Vertex we believe in",
        "start": 613.81,
        "duration": 3.27
    },
    {
        "text": "finding new treatments for these diseases.",
        "start": 617.08,
        "duration": 2.88
    },
    {
        "text": "But we just don't want treatments that",
        "start": 619.96,
        "duration": 2.05
    },
    {
        "text": "alleviate the symptoms, we want something",
        "start": 622.01,
        "duration": 1.82
    },
    {
        "text": "that can treat the underlying\ncause of the disease,",
        "start": 623.83,
        "duration": 2.55
    },
    {
        "text": "because that's as close\nas we can get to a cure.",
        "start": 626.38,
        "duration": 3.523
    },
    {
        "text": "But in order to do this\nwe need to overcome",
        "start": 630.84,
        "duration": 3.612
    },
    {
        "text": "some scientific challenges,",
        "start": 634.452,
        "duration": 3.988
    },
    {
        "text": "because there's gaps in the",
        "start": 638.44,
        "duration": 1.31
    },
    {
        "text": "biology knowledge of the disease,",
        "start": 639.75,
        "duration": 1.48
    },
    {
        "text": "sometimes we don't know\nexactly what the target is,",
        "start": 641.23,
        "duration": 2.74
    },
    {
        "text": "and sometimes when we have a target",
        "start": 643.97,
        "duration": 2.17
    },
    {
        "text": "these targets are hard to modulate,",
        "start": 646.14,
        "duration": 2.54
    },
    {
        "text": "the mechanism of actions,\nthey are not proven,",
        "start": 648.68,
        "duration": 2.65
    },
    {
        "text": "and usually we don't have a\ngood chemical matter to start.",
        "start": 651.33,
        "duration": 3.45
    },
    {
        "text": "But this is working in mostly",
        "start": 654.78,
        "duration": 3.58
    },
    {
        "text": "like in an unknown area.",
        "start": 658.36,
        "duration": 2.27
    },
    {
        "text": "But in Vertex we believe that we can do it",
        "start": 660.63,
        "duration": 1.92
    },
    {
        "text": "and one example for this is the work",
        "start": 662.55,
        "duration": 2.89
    },
    {
        "text": "of the company in cystic fibrosis.",
        "start": 665.44,
        "duration": 2.123
    },
    {
        "text": "And in this disease we\nhave taken leverage of",
        "start": 668.48,
        "duration": 3.832
    },
    {
        "text": "the knowledge of the\nbiology of the disease,",
        "start": 672.312,
        "duration": 1.999
    },
    {
        "text": "knowing that the gene\nthat cause the disease,",
        "start": 674.311,
        "duration": 2.054
    },
    {
        "text": "the protein that is affected and also",
        "start": 676.365,
        "duration": 2.485
    },
    {
        "text": "how the the mutants effect\nthis, it's function,",
        "start": 678.85,
        "duration": 3.48
    },
    {
        "text": "and now the scientists\nhave developed molecules",
        "start": 682.33,
        "duration": 2.36
    },
    {
        "text": "that can improve the\nfunction of CFTR mutants.",
        "start": 684.69,
        "duration": 2.91
    },
    {
        "text": "And the first example\nof that was Ivacaftor",
        "start": 687.6,
        "duration": 3.02
    },
    {
        "text": "that is now a drug that\nis approved by FDA,",
        "start": 690.62,
        "duration": 2.44
    },
    {
        "text": "and now is also being\nexplored in combination",
        "start": 693.06,
        "duration": 3.083
    },
    {
        "text": "regimes to expand the treatment",
        "start": 697.77,
        "duration": 2.92
    },
    {
        "text": "to a larger subset of\ncystic fibrosis patients.",
        "start": 702.66,
        "duration": 4.95
    },
    {
        "text": "And just for my last slide,",
        "start": 707.61,
        "duration": 3.183
    },
    {
        "text": "I would like to say that this is",
        "start": 711.93,
        "duration": 1.18
    },
    {
        "text": "a really exciting time to\ndo medicinal chemistry,",
        "start": 713.11,
        "duration": 2.963
    },
    {
        "text": "there's always new discoveries\nin the biology side,",
        "start": 717.06,
        "duration": 5.0
    },
    {
        "text": "and that comes with, that will enable new",
        "start": 722.46,
        "duration": 3.27
    },
    {
        "text": "chemical approaches to treat diseases,",
        "start": 725.73,
        "duration": 2.02
    },
    {
        "text": "new modes of action, new\nmechanisms of actions,",
        "start": 727.75,
        "duration": 2.53
    },
    {
        "text": "and if you think about\nthe tools that we have so far",
        "start": 730.28,
        "duration": 2.58
    },
    {
        "text": "they seem like more rudimentary.",
        "start": 732.86,
        "duration": 2.29
    },
    {
        "text": "When you look at the future, we will have",
        "start": 735.15,
        "duration": 1.49
    },
    {
        "text": "more advanced tools, more optimized tools,",
        "start": 736.64,
        "duration": 2.05
    },
    {
        "text": "and this will, what that will cause I think,",
        "start": 738.69,
        "duration": 2.3
    },
    {
        "text": "is what we see in the drug world today",
        "start": 740.99,
        "duration": 2.73
    },
    {
        "text": "might in the near future not be,",
        "start": 743.72,
        "duration": 2.99
    },
    {
        "text": "or might be druggable in the near future.",
        "start": 746.71,
        "duration": 3.29
    },
    {
        "text": "And this will have a great impact",
        "start": 750.0,
        "duration": 1.68
    },
    {
        "text": "to find new drugs that\ncan change people's lives.",
        "start": 751.68,
        "duration": 3.22
    },
    {
        "text": "And with that, I would\njust want to acknowledge",
        "start": 754.9,
        "duration": 2.43
    },
    {
        "text": "my Vanderbilt colleagues,\nmy MIT colleagues,",
        "start": 757.33,
        "duration": 4.5
    },
    {
        "text": "and also my Vertex colleagues.",
        "start": 761.83,
        "duration": 1.51
    },
    {
        "text": "All of them have played a really important",
        "start": 763.34,
        "duration": 2.88
    },
    {
        "text": "role in shaping my career.",
        "start": 766.22,
        "duration": 1.795
    },
    {
        "text": "Okay, thank you.",
        "start": 768.015,
        "duration": 1.989
    },
    {
        "text": "(audience applauding)",
        "start": 770.004,
        "duration": 2.917
    }
]